183 related articles for article (PubMed ID: 32173894)
1. Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine.
Kost Y; Zhu TH; Blasiak RC
Pediatr Dermatol; 2020 Jul; 37(4):748-749. PubMed ID: 32173894
[TBL] [Abstract][Full Text] [Related]
2. Intralesional human papillomavirus vaccine for the treatment of recalcitrant cutaneous warts.
Bar-Ilan E; Bar J; Baniel A; Slodownik D; Artzi O; Samuelov L; Sprecher E; Mashiah J
J Dermatol; 2023 Nov; 50(11):1373-1380. PubMed ID: 37501372
[TBL] [Abstract][Full Text] [Related]
3. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
Bossart S; Gabutti MP; Seyed Jafari SM; Hunger RE
Dermatol Ther; 2020 Jul; 33(4):e13771. PubMed ID: 32500585
[TBL] [Abstract][Full Text] [Related]
4. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
[TBL] [Abstract][Full Text] [Related]
6. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
Husein-ElAhmed H
Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against human papillomavirus is not associated with resolution of verruca vulgaris in immunocompetent 9- to 21-year olds.
Kost Y; Deutsch A; Zhu TH; Hulur I; Blasiak RC
J Am Acad Dermatol; 2022 Jul; 87(1):250-252. PubMed ID: 34418514
[No Abstract] [Full Text] [Related]
8. Characteristics of carcinogenic human papillomavirus infection in Suzhou: Epidemiology, vaccine evaluation, and associated diseases.
Li WJ; Xu HX; Chen ZH; Xu WD; Wu YJ
J Med Virol; 2017 May; 89(5):895-901. PubMed ID: 27696465
[TBL] [Abstract][Full Text] [Related]
9. Resolution of novel human papillomavirus-induced warts after HPV vaccination.
Silling S; Wieland U; Werner M; Pfister H; Potthoff A; Kreuter A
Emerg Infect Dis; 2014 Jan; 20(1):142-5. PubMed ID: 24378072
[TBL] [Abstract][Full Text] [Related]
10. Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine.
Smith SP; Baxendale HE; Sterling JC
Clin Exp Dermatol; 2017 Apr; 42(3):306-308. PubMed ID: 28070898
[TBL] [Abstract][Full Text] [Related]
11. Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.
Erkayman MH; Bilen H
Transpl Infect Dis; 2021 Aug; 23(4):e13572. PubMed ID: 33507618
[TBL] [Abstract][Full Text] [Related]
12. The Quadrivalent Human Papillomavirus Vaccine in Recalcitrant Non-genital Warts: A Retrospective Study.
Kuan LY; Chua SH; Pan JY; Yew YW; Tan WP
Ann Acad Med Singap; 2020 Oct; 49(10):749-755. PubMed ID: 33283838
[TBL] [Abstract][Full Text] [Related]
13. HPV vaccines to prevent cervical cancer and genital warts: an update.
Dochez C; Bogers JJ; Verhelst R; Rees H
Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
[TBL] [Abstract][Full Text] [Related]
14. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P
J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715
[TBL] [Abstract][Full Text] [Related]
15. Characterization and analysis of human papillomaviruses of skin warts.
Chen SL; Tsao YP; Lee JW; Sheu WC; Liu YT
Arch Dermatol Res; 1993; 285(8):460-5. PubMed ID: 8274034
[TBL] [Abstract][Full Text] [Related]
16. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study.
Coskuner ER; Ozkan TA; Karakose A; Dillioglugil O; Cevik I
J Sex Med; 2014 Nov; 11(11):2785-91. PubMed ID: 25124237
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart.
Köhler A; Gottschling M; Förster J; Röwert-Huber J; Stockfleth E; Nindl I
Virology; 2010 Mar; 399(1):129-133. PubMed ID: 20096912
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Regression of a Recalcitrant Wart after Bivalent Papillomavirus Vaccination.
Martin JM; Mateo E; Ramón D
J Pediatr; 2018 Mar; 194():259-259.e1. PubMed ID: 29274887
[No Abstract] [Full Text] [Related]
19. Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency.
Pastrana DV; Peretti A; Welch NL; Borgogna C; Olivero C; Badolato R; Notarangelo LD; Gariglio M; FitzGerald PC; McIntosh CE; Reeves J; Starrett GJ; Bliskovsky V; Velez D; Brownell I; Yarchoan R; Wyvill KM; Uldrick TS; Maldarelli F; Lisco A; Sereti I; Gonzalez CM; Androphy EJ; McBride AA; Van Doorslaer K; Garcia F; Dvoretzky I; Liu JS; Han J; Murphy PM; McDermott DH; Buck CB
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541782
[TBL] [Abstract][Full Text] [Related]
20. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
